AMPH (amphastar.com) Bozor qiymatining balans qiymatiga nisbati

Amphastar Pharmaceuticals Inc (AMPH) kompaniyasining rasmiy ramzlari

Amphastar Pharmaceuticals (AMPH) kompaniyasining tarixiy narxlar dinamikasi Osiyodan xomashyo importiga bog'liq bo'lgan kompaniyaning xatarlarini va xalqaro sertifikatsiyaning murakkabliklarini baholashga yordam beradi. Biznes shifoxona sarf materiallari bilan birga, inhalatsiya va inyeksiya mahsulotlari sotuvidan daromad keltiradi. Joriy ko'rsatkich 1.41 darajasida bo'lib, o'sish nasal glyukagon va generiklar hisobiga ta'minlanmoqda, yangi ishlab chiqilayotgan mahsulotlar portfelining salohiyati esa hali ham kutilmoqda.

AMPH Amphastar Corp: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Amphastar Pharmaceuticals Inc (AMPH) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Amphastar Pharmaceuticals|AMPH - Adolatli qiymat konsensusi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Amphastar|AMPH - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Amphastar Pharmaceuticals|AMPH - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati amphastar.com|AMPH - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Amphastar Pharmaceuticals|AMPH - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Amphastar|AMPH - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Amphastar|AMPH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Amphastar Pharmaceuticals
Kompaniyaning dastlabki tahlili:Amphastar Pharmaceuticals - AMPH
Amphastar original mahsuloti

Investorlar uchun haddan tashqari yuqori baholash risklarini filtrlash maqsadida Amphastar Pharmaceuticals (AMPH) aktivlari uchun to'langan premiumni kompaniyaning bozor qiymatini uning kapitaliga solishtirish orqali baholash juda muhimdir. Narxning buxgalteriya qiymatiga nisbati (price-to-book) koeffitsiyentidagi o'zgarishlarni tahlil qilish orqali, murakkab biosimilarlar va dori yetkazib berish tizimlariga kiritilgan investitsiyalar qanday qilib fundamental bazani shakllantirayotganini ko'rish mumkin, bu esa balans qiymati orqali biznesning operatsion barqarorligi va uzoq muddatli ishonchliligini tasdiqlaydi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati Haleon plc HLN|KVUE (kenvue.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ipatherapeutics.com (HYFT)|Bozor kapitallashuvining balans qiymatiga nisbati ABVC (ABVC BioPharma, Inc.)|Cumberland Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|QNTM: Bozor qiymatining balans qiymatiga nisbati|FGEN: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Telomir Pharmaceuticals (TELO)|Rani Therapeutics Holdings, Inc. (RANI) - Sof aktivlarga nisbatan bozor kapitallashuvi|SNYR - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Rallybio Corp.|Bozor kapitallashuvining balans qiymatiga nisbati LEXX|Bozor kapitallashuvining balans qiymatiga nisbati PULM (Pulmatrix Corporation)|Bozor qiymatining balans qiymatiga nisbati PTHL|APM - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Lyra Therapeutics LYRA|IBO - Bozor kapitallashuvining balans qiymatiga multiplikatori|TNFA: Bozor kapitallashuvining balans qiymatiga nisbati|YCBD (cbdMD) - Bozor kapitallashuvining balans qiymatiga nisbati|PRFX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical (CYTO)|Lipella Pharmaceuticals, Inc. (LIPO) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati OPTN (OptiNose Inc)|Pieris (PIRS) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Procaps Group Corp PROC|Bozor kapitallashuvining balans qiymatiga nisbati Petros Pharmaceuticals (PTPI)|QLI - Balans qiymatiga nisbatan bozor qiymati|SLRN: Bozor kapitallashuvining balans qiymatiga nisbati|TFFP (TFF Pharmaceuticals Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati